行情

DTIL

DTIL

Precision BioSciences
NASDAQ

实时行情|Nasdaq Last Sale

12.11
+0.31
+2.63%
盘后: 12.28 +0.17 +1.40% 18:46 11/15 EST
开盘
11.79
昨收
11.80
最高
12.39
最低
10.90
成交量
159.11万
成交额
--
52周最高
19.00
52周最低
6.24
市值
5.94亿
市盈率(TTM)
-7.8970
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

DTIL 新闻

  • 收盘:美股再创新高 道指首次跨越28000点里程碑
  • 新浪美股.5小时前
  • 周五美油期货收高1.7% 布油上涨1.6%
  • 新浪美股.5小时前
  • 分析师:某位投资大佬可能正在“嗅探”Netflix
  • 新浪财经.6小时前
  • FAA局长:737 MAX机型获复飞批准"不受时间表指引"
  • 新浪美股.6小时前

更多

所属板块

生物技术和医学研究
+1.35%
制药与医学研究
+1.27%

热门股票

名称
价格
涨跌幅

DTIL 简况

Precision BioSciences, Inc. is a genome editing company. The Company is engaged in providing genome engineering technology. The Company’s ARCUS genome editing technology enables the production of specific nucleases that can insert, remove and modify deoxyribonucleic acid (DNA) at any location in a genome. The Company is also engaged in developing genome editing-based product leads for human therapeutic, agricultural and biologics manufacturing applications. The Company’s four product candidates in its CAR T cell development pipeline are PBCAR0191, PBCAR20A, PBCAR269A and PBCAR371A. The Company’s ARCUS platform designed to treat human diseases and create healthy and sustainable food and agricultural solutions. It also developing product candidates in three areas to overcome the limitations of other genome editing technologies: allogeneic CAR T immunotherapy, in vivo gene correction, and food.
展开

Webull提供Precision BioSciences Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。